序号 |
标题 |
次数 |
作者 |
发布时间 |
82981 |
DOTAGA-rhCCK-9 |
94 |
wyh |
2024-11-28 |
82982 |
DOTA-Dglu-(Glu)5-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2的结构组成 |
108 |
wyh |
2024-11-28 |
82983 |
polylysine-(Gd-DOTA)的介绍 |
123 |
zyl |
2024-11-28 |
82984 |
(R)-DOTAGA-(COOt-Bu)4 817562-90-6 (R)-DOTAGA-四叔丁酯 |
103 |
zcy |
2024-11-28 |
82985 |
Azido-mono-amide-DOTA(B-288) |
137 |
zyl |
2024-11-28 |
82986 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
110 |
wyh |
2024-11-28 |
82987 |
3-羟基-5-取代芳基吡唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
107 |
WYQ |
2024-11-28 |
82988 |
氨基羧酸盐大环NOTA (N(3)O(3)) |
161 |
kx |
2024-11-28 |
82989 |
3,6-二对氯苯基-1,4-二氢-S-四嗪-1,4-二对甲基苯砜基 |
90 |
WYQ |
2024-11-28 |
82990 |
CAS:437608-50-9 Lutathera |
156 |
zyl |
2024-11-28 |
82991 |
3,6-二丙基-N,N'-二甲苯基-1,2,4,5-四嗪-1,4-二甲酰胺 |
101 |
WYQ |
2024-11-28 |
82992 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
82 |
wyh |
2024-11-28 |
82993 |
3,6-二胺基-1,2,4,5-四嗪(DAT) |
119 |
WYQ |
2024-11-28 |
82994 |
CAS:2057438-24-9 Dotatate tfa |
81 |
zyl |
2024-11-28 |
82995 |
3,6-二(对氯苄基)-s-四嗪 |
84 |
WYQ |
2024-11-28 |
82996 |
DOTA-cBR96 , DOTA偶联BR96单克隆抗体 |
108 |
kx |
2024-11-28 |
82997 |
p-NH2-Bn-DOTA-hu14.18K322A |
127 |
wyh |
2024-11-28 |
82998 |
3,6-二(对氯苯基)-s-四嗪 |
93 |
WYQ |
2024-11-28 |
82999 |
DOTA-tri(acid)-amido-PEG3-Bromoacetamide 定制 |
105 |
zcy |
2024-11-28 |
83000 |
CAS:306776-79-4 DOTAGA-tetra (t-Bu ester) |
109 |
zyl |
2024-11-28 |
83001 |
N,N'-二取代基-3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酰胺类化合物 |
108 |
WYQ |
2024-11-28 |
83002 |
DOTA-ZHER2:2891-Affibody |
153 |
wyh |
2024-11-28 |
83003 |
CAS:872469-60-8 大环化合物 |
79 |
zyl |
2024-11-28 |
83004 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)共轭GnRH肽 |
82 |
kx |
2024-11-28 |
83005 |
3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酸甲酯化合物 |
84 |
WYQ |
2024-11-28 |
83006 |
3-氧代-5-取代芳基异唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
81 |
WYQ |
2024-11-28 |
83007 |
cas:619300-53-7 DOTA-NOC;DOTA-Nal3-octreotide |
87 |
zcy |
2024-11-28 |
83008 |
CAS:157599-02-5 1,4,7,10-四(氨基羰甲基)-1,4,7,10-四氮杂环十二烷 |
82 |
zyl |
2024-11-28 |
83009 |
DOTA-peptide-(GGGF)-m170的结构组成 |
148 |
wyh |
2024-11-28 |
83010 |
DOTA-3P-RGD ,双功能螯合剂DOTA偶联环肽RGD二聚体 |
200 |
kx |
2024-11-28 |
83011 |
CAS:913542-71-9 DOTA di(tBu)ester |
86 |
zyl |
2024-11-28 |
83012 |
cas: 1192362-32-5 DOTA-LM3 |
105 |
zcy |
2024-11-28 |
83013 |
DOPE-PEG-DOTA 磷脂-聚乙二醇-大环配体 |
78 |
zyl |
2024-11-28 |
83014 |
DOTA-GX1 , 大环螯合剂DOTA缀合GX1肽 |
90 |
kx |
2024-11-28 |
83015 |
甲氧基DOTA;MeO-DOTA |
222 |
wyh |
2024-11-28 |
83016 |
cas:865470-67-3 DOTA-Thiol |
115 |
zcy |
2024-11-28 |
83017 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-烷基酮 |
86 |
WYQ |
2024-11-28 |
83018 |
DOTA-tris(acid)-amido-dPEG-TFP ester |
97 |
zyl |
2024-11-28 |
83019 |
DOTA-赖氨酸(DOTA-L) |
124 |
kx |
2024-11-28 |
83020 |
p-NH2-benzyl-NOTA; p-NH2-苄基-NOTA缀合物 |
89 |
wyh |
2024-11-28 |
83021 |
3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-甲酸酯 |
71 |
WYQ |
2024-11-28 |
83022 |
cas:1908409-18-6 DOTA Zoledronate DOTA唑来膦酸盐 |
81 |
zcy |
2024-11-28 |
83023 |
CAS:177943-88-3 DOTATATE |
82 |
zyl |
2024-11-28 |
83024 |
钆-四氮杂环十二烷-四乙酸 , LPS+Gd-DOTA |
104 |
kx |
2024-11-28 |
83025 |
N-取代苯基-3-芳基-6-甲基-1,6-二氢-1,2,4,5-四嗪-1-甲酰胺 |
159 |
WYQ |
2024-11-28 |